|
|
Volumn 34, Issue 5, 2002, Pages 1638-1639
|
|
Efficacy and safety of dual versus triple tacrolimus-based therapy in kidney transplantation: Two-year follow-up
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AZATHIOPRINE;
CORTICOSTEROID;
CYCLOSPORIN A;
METHYLPREDNISOLONE;
PREDNISONE;
TACROLIMUS;
IMMUNOSUPPRESSIVE AGENT;
ADULT;
BRONCHUS CANCER;
CANCER;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG SAFETY;
GRAFT REJECTION;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
KAPOSI SARCOMA;
KIDNEY CANCER;
KIDNEY TRANSPLANTATION;
LARYNX CANCER;
LEUKOPENIA;
MAJOR CLINICAL STUDY;
MULTICENTER STUDY;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
STOMACH CANCER;
STOMACH LYMPHOMA;
TREATMENT OUTCOME;
ADOLESCENT;
ARTICLE;
CHEMICALLY INDUCED DISORDER;
CLASSIFICATION;
COMPARATIVE STUDY;
DRUG COMBINATION;
FOLLOW UP;
IMMUNOLOGY;
INSULIN DEPENDENT DIABETES MELLITUS;
MIDDLE AGED;
POSTOPERATIVE COMPLICATION;
SPAIN;
TIME;
ADOLESCENT;
ADRENAL CORTEX HORMONES;
ADULT;
AZATHIOPRINE;
COMPARATIVE STUDY;
DIABETES MELLITUS, INSULIN-DEPENDENT;
DRUG THERAPY, COMBINATION;
FOLLOW-UP STUDIES;
HUMAN;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
LEUKOPENIA;
MIDDLE AGE;
POSTOPERATIVE COMPLICATIONS;
SPAIN;
SUPPORT, NON-U.S. GOV'T;
TACROLIMUS;
TIME FACTORS;
TREATMENT OUTCOME;
DIABETES MELLITUS, TYPE 1;
HUMANS;
MIDDLE AGED;
|
|
EID: 0035993675
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)02961-5 Document Type: Conference Paper |
|
Times cited : (8)
|
|
References (10)
|
